{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:30:47Z","timestamp":1787009447562,"version":"build-2736575974"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T00:00:00Z","timestamp":1521158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Visceral leishmaniasis (VL)-human immunodeficiency virus (HIV) coinfection remains a major problem in Ethiopia, India, and Brazil. Tuberculosis (TB), a treatable factor, could contribute to high mortality (up to 25%) in VL-HIV coinfection. However, the current evidence on the prevalence and clinical impact of TB in VL-HIV coinfection is very limited. In previous reports on routine care, TB prevalence ranged from 5.7% to 29.7%, but information on how and when TB was diagnosed was lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Field observations suggest that TB work-up is often not done systematically, and it is only done in patients who do not respond well to VL treatment. Here, we advocate high-quality diagnostic studies in VL-HIV-coinfected patients, during which all patients are systematically screened for TB, including a comprehensive work-up, to obtain reliable estimates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Cost-effective and feasible diagnostic algorithms can be developed for field use, and this can be integrated in VL clinical guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>An accurate diagnosis of TB can allow clinicians to assess its clinical impact and evaluate the impact of early TB diagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofy059","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T23:02:43Z","timestamp":1521154963000},"source":"Crossref","is-referenced-by-count":13,"title":["Tuberculosis in Visceral Leishmaniasis-Human Immunodeficiency Virus Coinfection: An Evidence Gap in Improving Patient Outcomes?"],"prefix":"10.1093","volume":"5","author":[{"given":"Johan","family":"van Griensven","sequence":"first","affiliation":[{"name":"Institute of Tropical Medicine, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rezika","family":"Mohammed","sequence":"additional","affiliation":[{"name":"University of Gondar, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koert","family":"Ritmeijer","sequence":"additional","affiliation":[{"name":"M\u00e9decins sans Fronti\u00e8res, Amsterdam, The Netherlands"},{"name":"M\u00e9decins sans Fronti\u00e8res, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakib","family":"Burza","sequence":"additional","affiliation":[{"name":"Drugs for Neglected Diseases Initiative, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermias","family":"Diro","sequence":"additional","affiliation":[{"name":"University of Gondar, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,3,16]]},"reference":[{"key":"2020081004274837200_CIT0001","doi-asserted-by":"crossref","first-page":"e2869","DOI":"10.1371\/journal.pntd.0002869","article-title":"Visceral leishmaniasis and HIV coinfection in East Africa","volume":"8","author":"Diro","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"2020081004274837200_CIT0002","doi-asserted-by":"crossref","first-page":"e3136","DOI":"10.1371\/journal.pntd.0003136","article-title":"Visceral leishmaniasis and HIV coinfection in Latin America","volume":"8","author":"Lindoso","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"2020081004274837200_CIT0003","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/cid\/ciu334","article-title":"Visceral leishmaniasis and HIV coinfection in Bihar, India: a wake-up call","volume":"59","author":"van Griensven","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2020081004274837200_CIT0004","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/cid\/ciu333","article-title":"HIV and visceral leishmaniasis coinfection in Bihar, India: an underrecognized and underdiagnosed threat against elimination","volume":"59","author":"Burza","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2020081004274837200_CIT0005","doi-asserted-by":"crossref","first-page":"e0005772","DOI":"10.1371\/journal.pntd.0005772","article-title":"Visceral leishmaniasis and HIV\/AIDS in Brazil: are we aware enough","volume":"11","author":"Leite de Sousa-Gomes","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2020081004274837200_CIT0006","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.idc.2012.03.005","article-title":"Visceral leishmaniasis","volume":"26","author":"van Griensven","year":"2012","journal-title":"Infect Dis Clin North Am"},{"key":"2020081004274837200_CIT0007","doi-asserted-by":"crossref","first-page":"361058","DOI":"10.1155\/2014\/361058","article-title":"Bacterial sepsis in patients with visceral leishmaniasis in Northwest Ethiopia","volume":"2014","author":"Endris","year":"2014","journal-title":"Biomed Res Int"},{"key":"2020081004274837200_CIT0008","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/1469-0691.12556","article-title":"Leishmaniasis in immunosuppressed individuals","volume":"20","author":"van Griensven","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2020081004274837200_CIT0009","first-page":"1","volume-title":"WHO policy on collaborative TB\/HIV activities: guidelines for national programmes and other stakeholders","author":"World Health Organization","year":"2012"},{"key":"2020081004274837200_CIT0010","first-page":"1","volume-title":"Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis amongst adults and adolescents: recommendations for HIV-prevalent and resource-constrained settings","author":"World Health Organization","year":"2006"},{"key":"2020081004274837200_CIT0011","doi-asserted-by":"crossref","first-page":"10931","DOI":"10.1038\/s41598-017-09895-7","article-title":"Disseminated tuberculosis among hospitalised HIV patients in South Africa: a common condition that can be rapidly diagnosed using urine-based assays","volume":"7","author":"Kerkhoff","year":"2017","journal-title":"Sci Rep"},{"key":"2020081004274837200_CIT0012","doi-asserted-by":"crossref","first-page":"e1511","DOI":"10.1371\/journal.pntd.0001511","article-title":"Early clinical manifestations associated with death from visceral leishmaniasis","volume":"6","author":"de Ara\u00fajo","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"2020081004274837200_CIT0013","doi-asserted-by":"crossref","first-page":"e2603","DOI":"10.1371\/journal.pntd.0002603","article-title":"Five-year field results and long-term effectiveness of 20 mg\/kg liposomal amphotericin B (Ambisome) for visceral leishmaniasis in Bihar, India","volume":"8","author":"Burza","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"2020081004274837200_CIT0014","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1093\/cid\/cir521","article-title":"Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India","volume":"53","author":"Sinha","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2020081004274837200_CIT0015","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/cid\/civ530","article-title":"Combination treatment for visceral leishmaniasis patients coinfected with human immunodeficiency virus in India","volume":"61","author":"Mahajan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2020081004274837200_CIT0016","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1365-3156.2010.02550.x","article-title":"Clinical characteristics and treatment outcome of patients with visceral leishmaniasis and HIV co-infection in northwest Ethiopia","volume":"15","author":"Hurissa","year":"2010","journal-title":"Trop Med Int Health"},{"key":"2020081004274837200_CIT0017","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12916-017-0822-8","article-title":"Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort","volume":"15","author":"Lawn","year":"2017","journal-title":"BMC Med"},{"key":"2020081004274837200_CIT0018","first-page":"147","article-title":"Renal involvement in leishmaniasis: a review of the literature","volume":"4","author":"Clementi","year":"2011","journal-title":"NDT Plus"},{"key":"2020081004274837200_CIT0019","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-3024.2006.00900.x","article-title":"Immune reconstitution disease associated with parasitic infections following antiretroviral treatment","volume":"28","author":"Lawn","year":"2006","journal-title":"Parasite Immunol"},{"key":"2020081004274837200_CIT0020","first-page":"486","article-title":"Visceral leishmaniasis and HIV co-infection in Northwest Ethiopia: antiretroviral treatment and burden of disease among patients enrolled in HIV care","volume-title":"Am J Trop Med Hyg","author":"van Griensven","year":"2018"},{"key":"2020081004274837200_CIT0021","doi-asserted-by":"crossref","first-page":"e0004087","DOI":"10.1371\/journal.pntd.0004087","article-title":"Use of pentamidine as secondary prophylaxis to prevent visceral leishmaniasis relapse in HIV infected patients, the first twelve months of a prospective cohort study","volume":"9","author":"Diro","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"2020081004274837200_CIT0022","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/cid\/cix807","article-title":"Long-term clinical outcomes in visceral leishmaniasis-HIV co-infected patients during and after pentamidine secondary prophylaxis in Ethiopia: a single-arm clinical trial authors and affiliations","volume":"66","author":"Diro","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2020081004274837200_CIT0023","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/cid\/cix607","article-title":"The risk and predictors of visceral leishmaniasis relapse in human immunodeficiency virus-coinfected patients in Ethiopia: a retrospective cohort study","volume":"65","author":"Abongomera","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2020081004274837200_CIT0024","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1093\/cid\/cir674","article-title":"Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence","volume":"53","author":"Ritmeijer","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2020081004274837200_CIT0025","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1086\/587899","article-title":"Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome","volume":"46","author":"ter Horst","year":"2008","journal-title":"Clin Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/5\/4\/ofy059\/33591130\/ofy059.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/5\/4\/ofy059\/33591130\/ofy059.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T21:55:55Z","timestamp":1719870955000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofy059\/4939174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,16]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofy059","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4]]},"published":{"date-parts":[[2018,3,16]]},"article-number":"ofy059"}}